Immunometabolic determinants of long-term response in leukemia patients receiving CD19 CAR T cell therapy.
Goldberg L, Haas ER, Wu J, Garcia B, Urak R, Vyas V, Espinosa R, Munoz T, Bierkatz S, Pathak KV, Hansen NP, Pirrotte P, Singhal J, Figarola JL, Noriega RZ, Li Z, Wi D, Tanaka E, Klein Geltink R, Chen MH, Wu X, Wagner JR, Paul J, Clark MC, Ngo D, Aldoss I, Forman SJ, Wang X.
Goldberg L, et al. Among authors: vyas v.
bioRxiv [Preprint]. 2025 Oct 24:2025.10.23.684261. doi: 10.1101/2025.10.23.684261.
bioRxiv. 2025.
PMID: 41278754
Free PMC article.
Preprint.